October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
Program Schedule
To view slides from a presenter click the icon next to the presentation title.
Friday, October 1 |
|
Session I: Basic Tumor Immunology |
|
| 8:05 am - 8:50 am | Innate Immunity and Inflammation Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center |
| 8:50 am - 9:35 am | Overview of Adaptive Immunity Emmanuel T. Akporiaye, PhD - Robert Franz Cancer Research Center, Earle A. Chiles Research Institute |
| 9:35 am - 10:20 am | Will Dendritic Cells Help Us Address the Challenge of Cancer Vaccines? A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research |
| 10:35 am - 11:20 am | Immunotherapeutic Barriers at the Level of the Tumor Microenvironment Thomas F. Gajewski, MD, PhD - University of Chicago |
| 11:20 am - 12:05 pm | Regulatory Immune Cells James H. Finke, PhD - Cleveland Clinic Foundation |
Session II: Clinical / Translational Cancer Immunology |
|
| 1:00 pm - 1:45 pm | Immune Monitoring Lisa H. Butterfield, PhD - University of Pittsburgh |
| 1:45 pm - 2:30 pm | Cytokines in Cancer Immunotherapy Kim A. Margolin, MD - Seattle Cancer Center Alliance |
| 2:30 pm - 3:15 pm | Immune Modulating Antibodies James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center |
| 3:30 pm - 4:15 pm | Cancer Vaccines Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute |
| 4:15 pm - 5:00 pm | Adoptive T-Cell Therapy Patrick Hwu, MD - MD Anderson Cancer Center |
| iSBTc 25th Annual Meeting For more information, click here. Saturday, October 2 - Monday, October 4 |
|
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
